Understanding Dual-Use Research of Concern

Defining Dual-Use Research

Dual-use research of concern (DURC) refers to life sciences research that, based on current understanding, can be reasonably anticipated to provide knowledge, information, products, or technologies that could be directly misapplied to pose a significant threat with broad potential consequences to public health and safety, agricultural crops and other plants, animals, the environment, materiel, or national security. The concept acknowledges a fundamental tension in biological research: the same knowledge that enables defense against infectious diseases can, in principle, be exploited to cause deliberate harm.

The formal recognition of DURC as a policy category emerged in the early 2000s, catalyzed by several high-profile research publications that demonstrated enhanced pathogen capabilities. The 2001 synthesis of poliovirus from commercially available oligonucleotides and the 2005 reconstruction of the 1918 influenza virus both illustrated that advancing scientific capability was making it increasingly feasible to create or modify dangerous pathogens. These developments prompted the scientific community, funding agencies, and national security establishments to develop governance frameworks for managing dual-use risks.

The Fink Report and Early Governance

The 2004 National Research Council report, commonly known as the Fink Report after committee chair Gerald Fink, established the foundational framework for DURC governance. The report identified seven categories of experiments that warranted additional oversight: those that would demonstrate how to render a vaccine ineffective; confer resistance to therapeutically useful antibiotics or antiviral agents; enhance the virulence of a pathogen or render a non-pathogen virulent; increase the transmissibility of a pathogen; alter the host range of a pathogen; enable the evasion of diagnostic or detection modalities; or enable the weaponization of a biological agent or toxin.

The Fink framework was deliberately broad, establishing categories of concern rather than prescriptive prohibitions. This approach recognized that the specific risks associated with any given experiment depend on context, including the pathogen involved, the technical details of the modification, the biosafety and biosecurity measures in place, and the potential for the knowledge to be replicated by actors with malicious intent. The framework placed primary responsibility for risk assessment at the institutional level, with oversight from Institutional Biosafety Committees (IBCs) and, for federally funded research, from funding agencies.

Gain-of-Function Research Debate

The most contentious subset of DURC involves gain-of-function (GoF) research, specifically experiments that enhance the transmissibility, virulence, or host range of potential pandemic pathogens. GoF research became a focal point of policy debate following the publication of studies in 2011-2012 that demonstrated airborne transmissibility of H5N1 avian influenza in ferret models. These experiments were conducted to understand the mutations required for pandemic potential, information considered valuable for surveillance and preparedness, but the research also generated detailed knowledge about how to make a highly lethal pathogen more transmissible.

The resulting policy response included a voluntary moratorium on certain GoF experiments, followed by the development of more structured review processes. The 2017 framework for enhanced potential pandemic pathogen (ePPP) research established a multi-layered review process involving institutional review, departmental review, and an independent expert panel. This framework requires that proposed ePPP research be evaluated against criteria including scientific merit, the availability of alternative approaches, the adequacy of risk mitigation measures, and the potential for the research to inform public health preparedness.

Risk Assessment Frameworks

Effective DURC governance requires systematic risk assessment methodologies that can evaluate the probability and consequences of misuse across diverse research contexts. Current frameworks generally assess risk along several dimensions: the technical accessibility of the knowledge or capability being generated; the potential consequences if the knowledge were misused; the availability of countermeasures or mitigations; the incremental risk posed by the specific research relative to existing knowledge; and the scientific and public health benefits of the research.

One of the persistent challenges in DURC risk assessment is the difficulty of evaluating misuse probability. Unlike biosafety risk assessment, which deals with accidental exposures and has actuarial data to inform probability estimates, biosecurity risk assessment must consider the intentions and capabilities of potential adversaries, a domain characterized by deep uncertainty. This has led to ongoing debate about whether DURC governance should focus primarily on consequence severity, which is more amenable to scientific evaluation, or attempt to incorporate threat probability, which requires intelligence assessments that may not be available to institutional review bodies.

Emerging Challenges: AI and Synthetic Biology

The convergence of artificial intelligence with biological research is creating new dual-use challenges that existing governance frameworks were not designed to address. Machine learning models trained on biological data can predict protein structures, design novel molecules, and optimize biological pathways with increasing accuracy. While these capabilities have enormous potential for drug discovery, diagnostics, and fundamental research, they also lower the barrier to designing biological agents with specific properties.

Synthetic biology tools, particularly advances in DNA synthesis and gene editing, compound these concerns by making it increasingly feasible to translate digital biological designs into physical organisms. The decreasing cost and increasing accessibility of DNA synthesis services, combined with the growing availability of pathogen genome sequences in public databases, creates a landscape in which the technical barriers to creating dangerous biological agents are progressively eroding.

Addressing these emerging challenges requires governance frameworks that extend beyond traditional research oversight to encompass the broader ecosystem of biological tools, data, and services. This includes screening of DNA synthesis orders, responsible disclosure practices for AI models with biological design capabilities, and international coordination on norms governing the intersection of AI and biology.

Balancing Openness and Security

The fundamental challenge of DURC governance is maintaining the openness that drives scientific progress while preventing the misuse of knowledge that could cause catastrophic harm. Excessive restriction risks impeding legitimate research that is essential for pandemic preparedness, disease treatment, and fundamental biological understanding. Insufficient oversight risks enabling the creation or enhancement of biological threats.

Achieving this balance requires a governance approach that is risk-proportionate, scientifically informed, internationally coordinated, and adaptive to evolving technologies. It also requires sustained engagement between the scientific community, national security professionals, ethicists, and policymakers to ensure that governance frameworks reflect both the current state of science and the evolving threat landscape. The stakes of getting this balance wrong, in either direction, are significant enough to warrant continued investment in the institutions, processes, and expertise needed to manage dual-use risks effectively.